Literature DB >> 17121865

RhoA activation in mesangial cells by mechanical strain depends on caveolae and caveolin-1 interaction.

Fangfang Peng1, Dongcheng Wu, Alistair J Ingram, Baifang Zhang, Bo Gao, Joan C Krepinsky.   

Abstract

Increased intraglomerular pressure is an important hemodynamic determinant of glomerulosclerosis and can be modeled in vitro by exposing mesangial cells to cyclic mechanical strain. A previous study showed that RhoA mediates strain-induced production of fibronectin; herein is investigated the role of caveolae in RhoA activation. Cyclodextrin and filipin, agents that disrupt caveolae, abrogated strain-induced RhoA activation in mesangial cells. Caveolin-1 (cav-1), the defining protein of caveolae, was Y14 phosphorylated by strain, and this was inhibited by PP1, showing Src dependence. Strain also induced c-SrcY416 phosphorylation and hence activation. Strain increased RhoA association with cav-1, which was blocked by PP1. Cyclodextrin and filipin inhibited the strain-induced RhoA/cav-1 association, indicating dependence on caveolar structural integrity. Restoration of caveolae by coincubation of cyclodextrin with cholesterol rescued both RhoA activation and RhoA/cav-1 association in response to strain. Sucrose gradient detected a significant portion of RhoA in caveolae, with Src located exclusively in these domains. Finally, in cells that were infected with retrovirus that encodes the nonphosphorylatable cav-1 Y14A, RhoA/cav-1 association, RhoA activation, and fibronectin secretion in response to strain were abrogated. It is concluded that strain-induced RhoA activation depends on the integrity of caveolae and on physical association of cav-1 and RhoA. The phosphorylation of cav-1 at Y14 by Src kinases is required for this to occur. These studies define a novel function for cav-1 and caveolae as positive effectors of RhoA activation. Targeting caveolae thus may provide a new therapeutic option for glomerular sclerosis that is associated with elevated intraglomerular pressure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17121865     DOI: 10.1681/ASN.2006050498

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

Review 1.  Rho kinase inhibition in diabetic kidney disease.

Authors:  Radko Komers
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

2.  Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1.

Authors:  Zhilong Ren; Wei Liang; Cheng Chen; Hongxia Yang; Pravin C Singhal; Guohua Ding
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

Review 3.  Caveolin-1 in the Pathogenesis of Diabetic Nephropathy: Potential Therapeutic Target?

Authors:  Richard Van Krieken; Joan C Krepinsky
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

4.  Caveolin-1 deficiency protects against mesangial matrix expansion in a mouse model of type 1 diabetic nephropathy.

Authors:  T H Guan; G Chen; B Gao; M R Janssen; L Uttarwar; A J Ingram; J C Krepinsky
Journal:  Diabetologia       Date:  2013-06-21       Impact factor: 10.122

5.  Co-regulation of caveolar and Cdc42-dependent fluid phase endocytosis by phosphocaveolin-1.

Authors:  Zhi-Jie Cheng; Raman Deep Singh; Eileen L Holicky; Christine L Wheatley; David L Marks; Richard E Pagano
Journal:  J Biol Chem       Date:  2010-03-12       Impact factor: 5.157

6.  Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.

Authors:  Rebecca S Henkhaus; Upal Kunal Basu Roy; Dora Cavallo-Medved; Bonnie F Sloane; Eugene W Gerner; Natalia A Ignatenko
Journal:  Neoplasia       Date:  2008-02       Impact factor: 5.715

7.  TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae.

Authors:  Fangfang Peng; Baifang Zhang; Dongcheng Wu; Alistair J Ingram; Bo Gao; Joan C Krepinsky
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-23

Review 8.  Small GTPases in mechanosensitive regulation of endothelial barrier.

Authors:  Konstantin G Birukov
Journal:  Microvasc Res       Date:  2008-09-30       Impact factor: 3.514

9.  Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population.

Authors:  Ruizhe Zhao; Kang Liu; Zhengkai Huang; Jun Wang; Yongsheng Pan; Yuan Huang; Xiaheng Deng; Jinliang Liu; Chao Qin; Gong Cheng; Lixin Hua; Jie Li; Changjun Yin
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

10.  Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds.

Authors:  Ivan Jozic; Beatriz Abdo Abujamra; Michael H Elliott; Tongyu C Wikramanayake; Jelena Marjanovic; Rivka C Stone; Cheyanne R Head; Irena Pastar; Robert S Kirsner; Fotios M Andreopoulos; Juan P Musi; Marjana Tomic-Canic
Journal:  Commun Biol       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.